Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.

Autor: Sissung TM; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Rockville, MD, USA., McKeeby JW; Department of Clinical Research Informatics, NIH Clinical Center, Bethesda, MD, USA., Patel J; Pharmacy Department, NIH Clinical Center, Bethesda, MD, USA., Lertora JJ; Clinical Pharmacology Program (2006-2016), NIH Clinical Center, Bethesda, MD, USA., Kumar P; Clinical Pharmacokinetics Research Laboratory, NIH Clinical Center, Bethesda, MD, USA., Flegel WA; Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD, USA., Adams SD; Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD, USA., Eckes EJ; Medical Surgical Specialties Service, Clinical Center Nursing Department, NIH, Bethesda, MD, USA., Mickey F; Department of Clinical Research Informatics, NIH Clinical Center, Bethesda, MD, USA., Plona TM; CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Mellot SD; CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Baugher RN; CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Wu X; Genomics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Soppet DR; Genomics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Barcus ME; CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Datta V; CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.; Molecular Characterization Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., Pike KM; CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, and Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA., DiPatrizio G; Department of Clinical Research Informatics, NIH Clinical Center, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Rockville, MD, USA., Goldspiel BR; Pharmacy Department, NIH Clinical Center, Bethesda, MD, USA.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2017 Oct; Vol. 57 Suppl 10, pp. S67-S77.